Expected value of implementation of icosapent ethyl in Sweden
Abstract Aim Cardiovascular disease poses a significant health and economic challenge in Europe, yet the adoption of novel cost-effective treatments like icosapent ethyl remains limited. This study aims to estimate the absolute and relative value of eliminating suboptimal implementation of icosapent...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-09-01
|
| Schriftenreihe: | BMC Health Services Research |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12913-025-13470-6 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|